Brands For Good Awards 2026
K Longevity (Robotimize Pte Ltd)
Executive Summary
United Nations - Sustainable Development Goals (SDG)
About The Company
About K LONGEVITY INFINITY
Established in 2022, K LONGEVITY INFINITY was born from a vision to redefine the boundaries of human health and longevity within the Chinese market. The organization operates at the intersection of biotechnology and preventive healthcare, focusing on the burgeoning field of regenerative medicine and biological age optimization.
Mission and Values
The company’s mission is centered on empowering individuals to optimize their biological potential and extend their "health span"—the period of life spent in good health. Driven by the core values of scientific integrity and personalized care, K LONGEVITY INFINITY utilizes data-driven protocols to provide bespoke health interventions that were once only available in clinical research settings.
Key Achievements
- Established a specialized longevity framework integrating NAD+ therapies and advanced bio-hacking technologies for the regional market.
- Successfully reached a revenue milestone of up to SGD $1M within its first two years of operation, demonstrating strong market demand for longevity services.
- Pioneered precision medicine outreach programs designed to make life-extending science accessible to a broader demographic.
Vision
K LONGEVITY INFINITY aims to become a leading voice in the global longevity sector, advocating for a future where biological aging is a manageable condition and evidence-based longevity tools are a standard component of global wellness.
Company Profile
Company
K Longevity (Robotimize Pte Ltd)
Category
BUSINESS FOR GOOD
Country
China
Year Established
2022
Staff Size
1-10
Website
globalongevity.com/about-us/About The Leadership
K LONGEVITY INFINITY is led by Founder and CEO Kerry, whose leadership journey reflects both global healthcare expertise and long-term entrepreneurial vision. Before entrepreneurship, Kerry spent nearly a decade in leadership roles at global pharmaceutical companies GlaxoSmithKline and Novartis, where she managed strategic projects, government affairs, and large-scale healthcare initiatives — building a strong foundation in healthcare systems, public-private collaboration, and long-term strategic planning.
She founded KWellness Group in China in 2014, successfully building a comprehensive health management business that has served leading multinational corporations and families across Asia. Rather than remaining in a stable and profitable business model, she made the bold decision to expand into rehabilitation medical technology — leading investments in R&D, global partnerships, and innovation. Today, her healthcare technology business spans more than 55 countries, supported by international laboratories, scientific advisors, and cross-border teams.
In 2022, Kerry launched K LONGEVITY INFINITY in Singapore as a next-generation longevity center, integrating advanced technologies from Germany, Japan, and Europe with evidence-based preventive health solutions. Her leadership philosophy is rooted in long-term thinking: making courageous decisions before markets fully mature, prioritizing responsibility over short-term growth, and ensuring innovation creates meaningful social impact. She leads with resilience, global perspective, and a deep commitment to helping people live longer, healthier, and higher-quality lives.
"行善为善"
Kerry Guo
Founder, CEO
K Longevity (Robotimize Pte Ltd)
Gallery
